Title: 2025-2026 Regular Session HR 249 PN 1836 Bill Text (HTM)
Official Title: 
Number of Sections: 1
Source: versions - Printer's No. PN1836
Media Type: text/html

================================================================================

Section 1:
2025-2026 Regular Session HR 249 PN 1836 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1836 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.249 Session of 2025 INTRODUCED BY RAPP, ZIMMERMAN, KAUFFMAN, CAUSER, ROWE, VENKAT, NEILSON, RIVERA AND GALLAGHER, JUNE 3, 2025 REFERRED TO COMMITTEE ON HEALTH, JUNE 4, 2025 A RESOLUTIONDesignating the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.WHEREAS, Idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen; andWHEREAS, Idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within three to five years; andWHEREAS, Idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; andWHEREAS, There is no proven cause of idiopathic pulmonary fibrosis, and it is often misdiagnosed or underdiagnosed; andWHEREAS, Idiopathic pulmonary fibrosis is five times more common than cystic fibrosis and Lou Gehrig's disease, yet the disease remains virtually unknown and receives a fraction of the 12345678910111213141516171819 research funding; andWHEREAS, More than 132,000 United States citizens have idiopathic pulmonary fibrosis and more than 50,000 new cases are diagnosed each year; andWHEREAS, 40,000 people die each year due to idiopathic pulmonary fibrosis, the same number as breast cancer; andWHEREAS, Approximately 7,000 Pennsylvanians suffer from idiopathic pulmonary fibrosis; andWHEREAS, This Commonwealth has become a leader in the research and treatment of idiopathic pulmonary fibrosis, with more than 15% of all lung transplants in the United States performed in Pennsylvania hospitals; andWHEREAS, Organizations like the Wescoe Foundation for Pulmonary Fibrosis and the Pennsylvania Idiopathic Pulmonary Fibrosis Support Network play a crucial role in raising awareness and providing support and education for patients, families and health care providers throughout this Commonwealth; andWHEREAS, Increased research, awareness and detection of idiopathic pulmonary fibrosis is needed; therefore be itRESOLVED, That the House of Representatives designate the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.20250HR0249PN1836 - 2 - 12345678910111213141516171819202122232425


================================================================================

Raw Text:
2025-2026 Regular Session HR 249 PN 1836 Bill Text (HTM) See other bills under thesame topic PRINTER'S NO. 1836 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE RESOLUTION No.249 Session of 2025 INTRODUCED BY RAPP, ZIMMERMAN, KAUFFMAN, CAUSER, ROWE, VENKAT, NEILSON, RIVERA AND GALLAGHER, JUNE 3, 2025 REFERRED TO COMMITTEE ON HEALTH, JUNE 4, 2025 A RESOLUTIONDesignating the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.WHEREAS, Idiopathic pulmonary fibrosis is a debilitating and generally fatal disease marked by progressive scarring of the lungs, causing an irreversible loss of the lung tissue's ability to transport oxygen; andWHEREAS, Idiopathic pulmonary fibrosis progresses quickly, often causing disability or death within three to five years; andWHEREAS, Idiopathic pulmonary fibrosis is the most common form of interstitial lung disease; andWHEREAS, There is no proven cause of idiopathic pulmonary fibrosis, and it is often misdiagnosed or underdiagnosed; andWHEREAS, Idiopathic pulmonary fibrosis is five times more common than cystic fibrosis and Lou Gehrig's disease, yet the disease remains virtually unknown and receives a fraction of the 12345678910111213141516171819 research funding; andWHEREAS, More than 132,000 United States citizens have idiopathic pulmonary fibrosis and more than 50,000 new cases are diagnosed each year; andWHEREAS, 40,000 people die each year due to idiopathic pulmonary fibrosis, the same number as breast cancer; andWHEREAS, Approximately 7,000 Pennsylvanians suffer from idiopathic pulmonary fibrosis; andWHEREAS, This Commonwealth has become a leader in the research and treatment of idiopathic pulmonary fibrosis, with more than 15% of all lung transplants in the United States performed in Pennsylvania hospitals; andWHEREAS, Organizations like the Wescoe Foundation for Pulmonary Fibrosis and the Pennsylvania Idiopathic Pulmonary Fibrosis Support Network play a crucial role in raising awareness and providing support and education for patients, families and health care providers throughout this Commonwealth; andWHEREAS, Increased research, awareness and detection of idiopathic pulmonary fibrosis is needed; therefore be itRESOLVED, That the House of Representatives designate the week of September 21 through 28, 2025, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania to increase awareness and understanding of idiopathic pulmonary fibrosis to support improved diagnosis and treatment.20250HR0249PN1836 - 2 - 12345678910111213141516171819202122232425